denosumab
amgen,daiichi sankyo
['denosumab']
#eular2023 clinical highlights. osteoarthritis. op0071 single centre phase 2 rct showed denosumab halted erosion in erosive oa at 24 weeks treatment, and the treatment effect enhances after 48 weeks vs pbo 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏